Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 3—March 2018
Research

Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan1

Yung-Feng Yen2, Sheng-Wei Pan, Vincent Yi-Fong Su2, Pei-Hung Chuang, Jia-Yih Feng3Comments to Author , and Wei-Juin Su3Comments to Author 
Author affiliations: National Yang-Ming University, Taipei, Taiwan (Y.-F. Yen, S.-W. Pan, V.Y.-F. Su, J.-Y. Feng, W.-J. Su); Taipei City Hospital, Taipei (Y.-F. Yen, V.Y.-F. Su); Taipei Veterans General Hospital, Taipei (S.-W. Pan, P.-H. Chuang, J.-Y. Feng, W.-J. Su)

Main Article

Table 3

Sensitivity analysis for the associations of influenza vaccination with incident TB after adjusting for demographic and medical characteristics, Taiwan, 2005–2012*

Study subgroup Incident TB, adjusted 
HR (95% CI)
All persons, n = 99,982 0.82 (0.73–0.93)‡
Age 65–69 y, n = 35,660 0.81 (0.64–1.03)
Age >70 y, n = 64,322 0.85 (0.67–1.08)
Male patients, n = 49,514 0.81 (0.70–0.93)‡
Female patients, n = 50,468 0.89 (0.68–1.17)
Patients with low income, n = 70,117 0.82 (0.71–0.94)‡
Patients with intermediate income, n = 17,045 1.04 (0.75–1.45)
Patients with high income, n = 12,820 0.62 (0.40–0.97)†
Patients in urban area, n = 25,012 0.71 (0.53–0.95)†
Patients in suburban area, n = 59,148 0.82 (0.70–0.96)†
Patients in rural area, n = 15,822 0.97 (0.73–1.28)
Diabetes patients, n = 21,029 0.80 (0.61–1.06)
Patients without diabetes, n = 78,953 0.83 (0.72–0.95)‡
Patients with CHF, n = 5,457 0.75 (0.43–1.30)
Patients without CHF, n = 94,525 0.82 (0.72–0.93)‡
Patients with COPD, n = 18,191 0.74 (0.58–0.94)†
Patients without COPD, n = 81,791 0.88 (0.76–1.02)
Patients with asthma, n = 9,439 0.79 (0.57–1.10)
Patients without asthma, n = 90,543 0.83 (0.73–0.95)‡
Patients with HTN, n = 53,442 0.86 (0.72–1.02)
Patients without HTN, n = 46,540 0.80 (0.66–0.96)†
Patients with CVD, n = 16,762 0.70 (0.51–0.97)†
Patients without CVD, n = 83,220 0.85 (0.74–0.97)†
Patients with cancer, n = 6,873 0.85 (0.55–1.31)
Patients without cancer, n = 93,109 0.81 (0.71–0.92)‡
Patients with CKD, n = 7,727 0.80 (0.53–1.20)
Patients without CKD, n = 92,255 0.82 (0.72–0.94)‡

*CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cerebral vascular disease; HR, hazard ratio; HTN, hypertension; TB, tuberculosis.
†p<0.05.
‡p<0.01.

Main Article

1The abstract of this study was presented at the 47th Union World Conference on Lung Health in Liverpool, United Kingdom, on October 27, 2016.

2These authors contributed equally to this article.

3These authors contributed equally to this article.

Page created: February 15, 2018
Page updated: February 15, 2018
Page reviewed: February 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external